Pfizer Inc. recalls Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-27…

Recall date

December 2, 2015

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

D-0520-2016

FDA classification

Class III

Brand / firm

Pfizer Inc.

Sold / distributed

Nationwide

Why it was recalled

Failed Dissolution Specification

Class III means the product violates regulations but is not likely to cause harm.

What was recalled

Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.